We next determined the significance of NURR1 overexpression in castration-relapse growth of prostate cancer cells using an established xenograft model of CRPC, that is based on the castration-relapse growth of AR-positive VCaP cells [34]. The gene discussed is NR4A2; the disease is prostate carcinoma.